RCAS1 decidual immunoreactivity in severe pre-eclampsia: Immune cell presence and activity

American Journal of Reproductive Immunology

Volumn 58, Issue 4, 2007, Pages 358-366

  Wicherek, Lukasz ^a   Basta, Pawel ^a   Sikora, Jerzy ^a   Galazka, Krystyna ^a   Rytlewski, Krzysztof ^a   Grabiec, Marek ^b   Lazar, Agata ^c   Kalinka, Jaroslaw ^d  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Decidua; Immune tolerance; Pre eclampsia; RCAS1

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; RECEPTOR BINDING CANCER ANTIGEN 1; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CD25+ T LYMPHOCYTE; CELL ACTIVITY; CELL INFILTRATION; CONTROLLED STUDY; DECIDUALIZATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREACTIVITY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD56; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, NEOPLASM; CASE-CONTROL STUDIES; DECIDUA; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTE COUNT; PRE-ECLAMPSIA; PREGNANCY; SEVERITY OF ILLNESS INDEX;

EID: 34548538205     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2007.00521.x     Document Type: Article

References (42)

1. Sibai B, Dekker G, Kupferminc M: Pre-eclampsia. Lancet 2005; 365: 785-799.
2. Redman CW, Sargent IL: Latest advances in understanding preeclampsia. Science 2005; 308: 1592-1594.
3. Robillard PY: Interest in preclampsia for researchers in reproduction. J Reprod Immunol 2002; 53: 279-287.
4. Wilczynski JR: Immunological analogy between allograft rejection, recurrent abortion and pre-eclampsia- the same basic mechanism. Hum Immunol 2006; 67: 492-511.
5. Huppertz B, Hemmings D, Renaud SJ, Bulmer JN, Dash P, Chamley LW: Extravillous trophoblat apotosis - a workshop report. Placenta 2005; 26(Suppl A): S46-S48.
6. Trundley A, Moffett A: Human uterine leukocytes and pregnancy. Tissue Antigens 2004; 63: 1-12.
7. Azizieh F, Raghupathy R, Makhseed M: Maternal cytokine production patterns in women with pre-eclampsia. Am J Reprod Immunol 2005; 54: 30-37.
8. Brown DW:APre-eclampsia: a mistake of trophoblastic cells for tumor cells?. Med Hypotheses 1999; 53: 124-126.
9. Naicker T, Khedun SM, Moodley J, Pijnenborg R: Quantitative analysis of trophoblast invasion in preeclampsia. Acta Obstet Gynecol Scand 2003; 82: 722-779.
10. Allaire AD, Ballenger KA, Wells SR, Mcmahon MJ, Lessey BA: Placental apotosis in preeclampsia. Obstet Gynecol 2000; 96: 271-276.
11. Wilczynski JR, Tchorzewski H, Banasik M, Glowacka E, Wieczorek A, Lewkowicz P, Malinowski A, Szpakowski M, Wilczynski J: Lymphocyte subset distribution and cytokinez secretion in third trimester decidua in normal pregnancy and preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003; 109: 8-15.
12. Raghupathy R, Al Mutawa E, Makhseed M, Azizieh F, Szekeres-Bartho J: Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage. BJOG 2005; 112: 1096-1101.
13. Wicherek L, Galazka K, Lazar A: RCAS1 decidual immunoreactivity during placental abruption: Immune cell presence and activity. Am J Reprod Immunol 2007; 58: 46-55.
14. Qiu Q, Yang M, Tsang BK, Gruslin A: Fas ligand expression by maternal decidual cells is negatively correlated with the abundance of leukocytes present at the maternal-fetal interface. J Reprod Immunol 2005; 65: 121-132.
15. Eide IP, Isaksen CV, Salvesen KA, Langaas M, Gunther CC, Iversen AC, Austgulen R: Fetal growth restriction is assosiated with reduced FasL expression by decidual cells. J Reprod Immunol 2007; 74: 1-14.
16. Wicherek L, Popiela TJ, Galazka K, Dutsch-Wicherek M, Oplawski M, Basta A, Klimek M: Metallothionein and RCAS1 expression in comparison to immunological cells activity in endometriosis, endometrial adenocarcinoma and the endometrium according to menstrual cycle changes. Gynecol Oncol 2005; 99: 622-630.
17. Nakashima M, Sonoda K, Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 1999; 5: 938-942.
18. Sonoda K, Kaku T, Hirakawa T, Kobayashi H, Amada S, Sakai K, Nakashima M, Watanabe T, Nakano H: The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium. Gynecol Oncol 2000; 79: 424-429.
19. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer. Gynecol Oncol 2005; 97: 772-779.
20. Nakabayashi H, Nakashima M, Hara M, Toyonaga S, Yamada SM, Park KC, Shimizu K: Clinico-pathological significance of RCAS1 expression in gliomas: A potential mechanism of tumor immune escape. Cancer Lett 2007; 246: 182-189.
21. Kawano Y, Kaku T, Sonoda K, Hirakawa T, Kobayashi H, Ohishi Y, Nakano H: Expression of RCAS1 in female genital organs. Int J Gynecol Pathol 2005; 24: 330-334.
22. Ohshima K, Nakashima M, Sonoda K, Kikuchi M, Watanabe T: Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: The possible role in immune privilege. Clin Exp Immunol 2001; 123: 481-486.
23. Dutsch-Wicherek M, Tomaszewska R, Popiela TJ, Wicherek L, Szywala M, Wierzchowski W, Modrzejewski M, Klimek M, Czekierdowska S, Skladzien J: RCAS1 expression in lymphoid tissue of Waldeyer's ring. Pol J Environ Stud 2005; 14(Suppl. 2): 73-76.
24. Matsushima T, Nakashima M, Oshima K, Abe Y, Nishimura J, Nawata H, Watanabe T, Muta K: Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. Blood 2001; 98: 313-321.
25. Wicherek L, Klimek M, Galazka K, Obrzut B: Cycle dependent RCAS1 expression with respect to the immune cells presence and activity. Neuro Endocrinol Lett 2006; 27: 645-650.
26. Wicherek L, Klimek M, Dutsch-Wicherek M, Kolodziejski L, Skotniczny K: The molecular changes during placenta detachment. Eur J Obstet Gynecol Reprod Biol 2006; 125: 171-175.
27. Wicherek L, Galazka K, Lazar A: The analysis of metallothionein, RCAS1 immunoreactivity regarding immune cells concentration in endometrium and tubal mucosa in ectopic pregnancy during the course of tubal rupture. Gynecol Obstet Invest 2007; in press.
28. Rytlewski K, Olszanecki R, Korbut R, Zdebski Z: Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur J Clin Invest 2005; 35: 32-37.
29. Steinborn A, Rebmann V, Scharf A, Sohn C, Grosse-Wilde H: Placental abruption is associated with decreased maternal plasma levels of soluble HLA-G. J Clin Immunol 2003; 23: 307-314.
30. Steinborn A, Rebmann V, Scharf A, Sohn C, Grosse-Wilde H: Soluble HLA-DR levels in the maternal circulation of normal and pathologic pregnancy. Am J Obstet Gynecol 2003; 188: 473-479.
31. + T lymphocytes in normal pregnancies. Mol Hum Reprod 2002; 8: 667-673.
32. Eide IP, Rolfseng T, Isaksen CV, Mecsei R, Roald B, Lydersen S, Salvesen KA, Harsem NK, Austgulen R: Serious foetal grotwth restriction is associated with reduced proportions of natural killer cells in decidua basalis. Virchows Arch 2006; 448: 269-276.
33. Stallmach T, Hebisch G, Orban P, Lu X: Aberrant positioning of trophoblast and lymphoctes in the feto-maternal interface with pre-eclampsia. Virchows Arch 1999; 434: 207-211.
34. Bachmayer N, Rafik-Hamad R, Liszka L, Bremme K, Sverremark-Ekstrom E: Aberrant uterine natural killer (NK)-cell expression and altered placental and serum levels of the NK-cell promoting cytokine interleukin-12 in pre-eclampsia. Am J Reprod Immunol 2006; 56: 292-301.
35. Kalinka J, Sobala W, Wasiela M, Brzezinska-Blaszczyk E: Decreased proinflmatory cytokines in cervicovaginal fluid as measured in midgestation, are associated with preterm delivery. Am J Reprod Immunol 2005; 54: 70-76.
36. Sindram-Trujillo A, Scherjon S, Kanhai H, Roelen D, Class F: Increased T-cell activation in decidua parietalis compared to decidua basalis in uncomplicated human term pregnancy. Am J Reprod Immunol 2003; 49: 261-268.
37. Darmochwal-Kolarz D, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J: Fas antigen expression on the decidua lymphocytes of pre-eclamptic patients. Am J Reprod Immunol 2000; 43: 197-201.
38. Saito S, Sakai M, Sasaki Y, Tanebe K, Tsuda H, Michimata T: Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1: Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 1999; 117: 550-555.
39. Chaouat G, Ledee-Bataille N, Zourbas S, Dubanchet S, Sandra O, Martal J, OstojojiC S, Frydman R: Implantation: can immunological parameters of implantation failure be of interest for pre-eclampsia?. J Reprod Immunol 2003; 59: 205-217.
40. Ledee-Bataille N, Bonnet-Chea K, Hosny G, Dubanchet S, Frydman R, Chaouat G: Role of the endometrial tripod interleukin-18, -15, and -12 in inadequate uterine receptivity in patients with a history of repeated in vitro fertilization-embryo transfer failure. Fertil Steril 2005; 83: 598-605.
41. Ordi J, Casals G, Ferrer B, Creus M, Guix C, Palacin A, Campo E, Balasch J: Uterine (CD56+) natural Killer cells recrAitment: association with decidual reaction rather than embryo implantation. Am J Reprod Immunol 2006; 55: 369-377.
42. Wicherek L, Klimek M, Dutsch-Wicherek M: The level of maternal immune tolerance and fetal maturity. Neuro Endocrinol Lett 2005; 26: 561-566.